1. Home
  2. EBON vs SER Comparison

EBON vs SER Comparison

Compare EBON & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ebang International Holdings Inc.

EBON

Ebang International Holdings Inc.

HOLD

Current Price

$2.22

Market Cap

16.0M

Sector

Technology

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

HOLD

Current Price

$2.60

Market Cap

42.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EBON
SER
Founded
2010
2017
Country
China
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.0M
42.0M
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
EBON
SER
Price
$2.22
$2.60
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
5.1K
58.2K
Earning Date
04-24-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$130,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
132.14
52 Week Low
$1.61
$1.22
52 Week High
$5.90
$5.83

Technical Indicators

Market Signals
Indicator
EBON
SER
Relative Strength Index (RSI) 53.22 56.37
Support Level $1.73 $1.69
Resistance Level $2.29 $2.95
Average True Range (ATR) 0.14 0.19
MACD 0.01 -0.03
Stochastic Oscillator 66.83 51.29

Price Performance

Historical Comparison
EBON
SER

About EBON Ebang International Holdings Inc.

Ebang International Holdings Inc is engaged in blockchain technology and fintech, with activities also extending to the solar industry, supported by its application-specific integrated circuit (ASIC) chip designs. The Company's business mainly includes the sale of bitcoin mining machines and related accessories, telecommunication products, solar and battery storage products, cryptocurrency exchange services, cross-border payment and foreign exchange services, SaaS data visualization and analytics solutions, and rental services. It generates the majority of its revenue from cross-border payment and foreign exchange services, with its operations mainly in mainland China and Australia, which contribute the maximum revenue.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The company has one reportable segment relating to the research and development of its POZ platform. The segment derives its revenues from Grant revenue. Its main product candidate, SER-252 for advanced Parkinson's disease, is anticipated to enter clinical trials.

Share on Social Networks: